• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于年龄的甲状腺乳头状癌全甲状腺切除术应用差异。

Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.

机构信息

UC Davis School of Medicine, Sacramento, CA, USA.

Department of Surgery, The Everett Clinic, Medical Office Building, 1330 Rockefeller Avenue, Everett, WA, 98201, USA.

出版信息

Clin Transl Oncol. 2017 Oct;19(10):1253-1259. doi: 10.1007/s12094-017-1663-9. Epub 2017 Apr 24.

DOI:10.1007/s12094-017-1663-9
PMID:28439795
Abstract

BACKGROUND

Elderly patients may be less likely than younger patients to receive indicated therapy. We hypothesized that older patients with papillary thyroid carcinoma (PTC) would be less likely to receive total thyroidectomy (TT) than their younger counterparts.

MATERIALS AND METHODS

The Surveillance, Epidemiology, and End Results database were queried for adult patients diagnosed with PTC from 2000 through 2009. Patients were categorized according to whether they received a TT or less than a total thyroidectomy (<TT). We used multivariate logistic regression to predict the use of <TT. The likelihood of undergoing <TT was reported as odds ratios (OR) with 95% confidence intervals (CI).

RESULTS

Of the 67,961 patients identified with PTC, 51,276 (75%) received TT, 14,750 (22%) <TT and 1935 (3%) no surgery. On multivariate analysis, advancing age increased the likelihood of receiving <TT (age 45-54 OR 1.15, CI [1.09-1.20]; age 55-64 OR 1.20, CI [1.14-1.26]; age 65-74 OR 1.40, CI [1.32-1.49]; 75-84 OR 1.80, CI [1.65-1.95]; ≥85 OR 3.01, CI [2.51-3.62], all p < 0.001).

CONCLUSIONS

Older patients with PTC are less likely to receive TT. Further research is needed to assess if older patients are negatively impacted by less complete surgery.

摘要

背景

与年轻患者相比,老年患者接受指示性治疗的可能性较低。我们假设,与年轻的甲状腺乳头状癌(PTC)患者相比,老年患者接受甲状腺全切除术(TT)的可能性较低。

材料和方法

从 2000 年到 2009 年,对诊断为 PTC 的成年患者进行了监测、流行病学和最终结果数据库查询。根据患者是否接受 TT 或不完全甲状腺切除术(<TT)进行分类。我们使用多元逻辑回归来预测 <TT 的使用情况。<TT 的可能性以优势比(OR)和 95%置信区间(CI)报告。

结果

在 67961 例 PTC 患者中,51276 例(75%)接受了 TT,14750 例(22%)<TT,1935 例(3%)未接受手术。在多变量分析中,年龄的增加增加了接受 <TT 的可能性(45-54 岁 OR 1.15,CI [1.09-1.20];55-64 岁 OR 1.20,CI [1.14-1.26];65-74 岁 OR 1.40,CI [1.32-1.49];75-84 岁 OR 1.80,CI [1.65-1.95];≥85 岁 OR 3.01,CI [2.51-3.62],所有 p<0.001)。

结论

患有 PTC 的老年患者接受 TT 的可能性较低。需要进一步研究以评估老年患者是否因手术不完整而受到负面影响。

相似文献

1
Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.基于年龄的甲状腺乳头状癌全甲状腺切除术应用差异。
Clin Transl Oncol. 2017 Oct;19(10):1253-1259. doi: 10.1007/s12094-017-1663-9. Epub 2017 Apr 24.
2
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States.美国分化型甲状腺癌的AMES预后指数与甲状腺切除范围
Surgery. 2004 Sep;136(3):609-16. doi: 10.1016/j.surg.2003.12.009.
3
The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.社会经济地位对甲状腺乳头状癌辅助放射性碘治疗应用的影响。
Thyroid. 2014 Apr;24(4):758-63. doi: 10.1089/thy.2013.0409. Epub 2014 Feb 3.
4
Surgery for papillary thyroid carcinoma: is lobectomy enough?甲状腺乳头状癌手术:肺叶切除术足够了吗?
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1055-61. doi: 10.1001/archoto.2010.181.
5
The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross-sectional study.甲状腺微小乳头状癌患者行腺叶切除术或甲状腺全切除术的生活质量:一项横断面研究。
Cancer Med. 2021 Mar;10(6):1989-2002. doi: 10.1002/cam4.3747. Epub 2021 Feb 26.
6
Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.甲状腺切除范围并非低危或高危乳头状甲状腺癌患者生存的主要决定因素。
Ann Surg Oncol. 2005 Jan;12(1):81-9. doi: 10.1007/s10434-004-1165-1. Epub 2004 Dec 27.
7
Utilization of total thyroidectomy for papillary thyroid cancer in the United States.美国甲状腺全切除术在乳头状甲状腺癌治疗中的应用。
Surgery. 2007 Dec;142(6):906-13; discussion 913.e1-2. doi: 10.1016/j.surg.2007.09.002. Epub 2007 Nov 5.
8
Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.儿童局限性甲状腺乳头状癌行甲状腺全切除术与甲状腺叶切除术的生存分析:倾向评分匹配研究。
J Am Coll Surg. 2021 Jul;233(1):39-49. doi: 10.1016/j.jamcollsurg.2021.03.025. Epub 2021 Apr 19.
9
Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience.对于单侧多灶性甲状腺微小乳头状癌,全甲状腺切除术作为初始手术可能更为合理:单中心经验
World J Surg Oncol. 2017 Mar 16;15(1):62. doi: 10.1186/s12957-017-1130-7.
10
Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.手术范围对45岁以下甲状腺乳头状癌患者生存的影响。
J Clin Endocrinol Metab. 2015 Jan;100(1):115-21. doi: 10.1210/jc.2014-3039.

引用本文的文献

1
Disparities in the Place of Death for Patients With Malignant Neoplasms of the Thyroid Gland.甲状腺恶性肿瘤患者死亡地点的差异
Cureus. 2024 Mar 4;16(3):e55506. doi: 10.7759/cureus.55506. eCollection 2024 Mar.
2
Operative Management of Thyroid Disease in Older Adults.老年人甲状腺疾病的手术治疗
J Endocr Soc. 2023 May 31;7(7):bvad070. doi: 10.1210/jendso/bvad070. eCollection 2023 Jun 5.
3
Meis homeobox 2 (MEIS2) inhibits the proliferation and promotes apoptosis of thyroid cancer cell and through the NF-κB signaling pathway.

本文引用的文献

1
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
3
Long-term outcomes for older patients with papillary thyroid carcinoma: should another age cutoff beyond 45 years be added?
Meis 同源盒 2(MEIS2)通过 NF-κB 信号通路抑制甲状腺癌细胞的增殖并促进其凋亡。
Bioengineered. 2021 Dec;12(1):1766-1772. doi: 10.1080/21655979.2021.1923354.
4
Thyroidectomy in elderly patients aged ≥70 years.≥70岁老年患者的甲状腺切除术
Gland Surg. 2017 Oct;6(5):587-590. doi: 10.21037/gs.2017.10.01.
老年甲状腺乳头状癌患者的长期预后:是否应增加45岁以上的另一个年龄界限?
Ann Surg Oncol. 2015 Feb;22(2):446-53. doi: 10.1245/s10434-014-4055-1. Epub 2014 Sep 5.
4
Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma.预测晚期甲状腺乳头状癌治疗遵循美国甲状腺协会指南情况的人口统计学和社会经济因素。
Head Neck. 2015 Dec;37(12):1776-80. doi: 10.1002/hed.23831. Epub 2014 Sep 25.
5
Age and prognosis of papillary thyroid carcinoma: retrospective stratification into three groups.甲状腺乳头状癌的年龄与预后:回顾性分为三组
J Korean Surg Soc. 2012 Nov;83(5):259-66. doi: 10.4174/jkss.2012.83.5.259. Epub 2012 Oct 29.
6
A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.基于监测、流行病学和最终结果(SEER)登记处,对美国癌症联合委员会(AJCC)用于年轻分化型甲状腺癌患者的分期系统进行批判性分析。
Surgery. 2012 Aug;152(2):145-51. doi: 10.1016/j.surg.2012.02.015. Epub 2012 Apr 11.
7
The impact of age and gender on papillary thyroid cancer survival.年龄和性别对甲状腺乳头状癌生存的影响。
J Clin Endocrinol Metab. 2012 Jun;97(6):E878-87. doi: 10.1210/jc.2011-2864. Epub 2012 Apr 10.
8
Reevaluating the prognostic significance of age in differentiated thyroid cancer.重新评估年龄在分化型甲状腺癌中的预后意义。
Otolaryngol Head Neck Surg. 2012 Aug;147(2):221-6. doi: 10.1177/0194599812441587. Epub 2012 Mar 30.
9
Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study.甲状腺乳头状癌患者预后与年龄的关系:一项回顾性单机构研究。
Endocr J. 2012;59(5):399-405. doi: 10.1507/endocrj.ej12-0044. Epub 2012 Feb 29.
10
Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age.甲状腺乳头状癌的预后因素因性别和患者年龄而异。
World J Surg. 2011 Dec;35(12):2684-90. doi: 10.1007/s00268-011-1288-z.